Cargando…
Clinical, genetic, and experimental research of hyperphenylalaninemia
Hyperphenylalaninemia (HPA) is the most common amino acid metabolism defect in humans. It is an autosomal-recessive disorder of the phenylalanine (Phe) metabolism, in which high Phe concentrations and low tyrosine (Tyr) concentrations in the blood cause phenylketonuria (PKU), brain dysfunction, ligh...
Autores principales: | Chen, Anqi, Pan, Yukun, Chen, Jinzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845280/ https://www.ncbi.nlm.nih.gov/pubmed/36685931 http://dx.doi.org/10.3389/fgene.2022.1051153 |
Ejemplares similares
-
Micronutrient in hyperphenylalaninemia
por: Crujeiras, Vanesa, et al.
Publicado: (2015) -
Case Report: Severe Hypotonia Without Hyperphenylalaninemia Caused by a Homozygous GCH1 Variant: A Case Report and Literature Review
por: Chen, Yun, et al.
Publicado: (2022) -
Stress Hyperphenylalaninemia Is Associated With Mortality in Cardiac ICU: Clinical Factors, Genetic Variants, and Pteridines*
por: Wang, Chao-Hung, et al.
Publicado: (2022) -
Mild hyperphenylalaninemia: to treat or not to treat
por: van Spronsen, Francjan J.
Publicado: (2011) -
Cognitive functioning in mild hyperphenylalaninemia
por: de la Parra, Alicia, et al.
Publicado: (2015)